About dare bioscience inc - DARE
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley on November 28, 2005 and is headquartered in San Diego, CA.
DARE At a Glance
Daré Bioscience, Inc.
3655 Nobel Drive
San Diego, California 92122
| Phone | 1-858-926-7655 | Revenue | 1.03M | |
| Industry | Pharmaceuticals: Major | Net Income | -13,399,274.00 | |
| Sector | Health Technology | 2025 Sales Growth | 10,429.364% | |
| Fiscal Year-end | 12 / 2026 | Employees | 24 | |
| View SEC Filings |
DARE Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 20.943 |
| Price to Book Ratio | 9.844 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.431 |
| Enterprise Value to Sales | 4.774 |
| Total Debt to Enterprise Value | 1.638 |
DARE Efficiency
| Revenue/Employee | 42,924.708 |
| Income Per Employee | -558,303.083 |
| Receivables Turnover | 1.798 |
| Total Asset Turnover | 0.038 |
DARE Liquidity
| Current Ratio | 1.143 |
| Quick Ratio | 1.143 |
| Cash Ratio | 1.043 |
DARE Profitability
| Gross Margin | -137.546 |
| Operating Margin | -1,315.514 |
| Pretax Margin | -1,300.657 |
| Net Margin | -1,300.657 |
| Return on Assets | -49.103 |
| Return on Equity | N/A |
| Return on Total Capital | -122.96 |
| Return on Invested Capital | -323.615 |
DARE Capital Structure
| Total Debt to Total Equity | 283.35 |
| Total Debt to Total Capital | 73.914 |
| Total Debt to Total Assets | 24.803 |
| Long-Term Debt to Equity | 209.181 |
| Long-Term Debt to Total Capital | 54.566 |
Dare Bioscience Inc in the News
Bill & Melinda Gates Foundation gives Dare Bioscience a boost
Shares of Daré Bioscience, Inc., surged 63% ahead of Wednesday's opening bell after the biotech company reported a nearly $49 million grant from The Bill & Melinda Gates Foundation.